During the past decade, Complejo Hospitalario de Cáceres conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Complejo Hospitalario de Cáceres" #1 collaborator was "Celgene" with 2 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator, "Adknoma" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Dynamic Science S.L." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Complejo Hospitalario de Cáceres" are "Acute Lymphoblastic Leukemia" (3 trials), "Multiple Myeloma" (3 trials), "Newly Diagnosed Multiple Myeloma" (2 trials), "Acute Lymphoblastic Leukemia Ph Positive" (1 trials) and "Acute Myeloblastic Leukemia" (1 trials). Many other conditions were trialed in "Complejo Hospitalario de Cáceres" in a lesser frequency.

Most popular intervention types in "Complejo Hospitalario de Cáceres" are "Drug" (13 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (6 trials), "Prednisone" (3 trials), "Bortezomib" (2 trials), "Carfilzomib" (2 trials) and "Lenalidomide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Complejo Hospitalario de Cáceres" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Complejo Hospitalario de Cáceres". 1 are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Complejo Hospitalario de Cáceres, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Complejo Hospitalario de Cáceres, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".